6-(6-hydroxymethyl-pyrimidin-4-yloxy)naphthalene-1-carboxylic acid (3-trifluoromethylphenyl)-amid compound

Abstract

The invention relates to a compound 6-(6Hydroxymethyl-pyrimidin-4-yloxy)- naphthalene1-carboxylic acid (3-trifluoromethyl-phenyl)-amide and to a pharmaceutical composition comprising this compound for use in the treatment of protein kinase dependent diseases, especially of proliferative diseases, such as in particular tumour diseases.